|
BTBD12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.75200000000531E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.717100E-03 |
| Normal-vs-Stage2 |
9.022400E-02 |
| Normal-vs-Stage3 |
1.285530E-02 |
| Normal-vs-Stage4 |
3.093600E-01 |
| Stage1-vs-Stage2 |
5.288600E-01 |
| Stage1-vs-Stage3 |
4.496200E-01 |
| Stage1-vs-Stage4 |
8.732000E-01 |
| Stage2-vs-Stage3 |
8.456600E-01 |
| Stage2-vs-Stage4 |
7.575400E-01 |
| Stage3-vs-Stage4 |
8.012000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.41370000000552E-05 |
| Normal-vs-AfricanAmerican |
1.012420E-01 |
| Normal-vs-Asian |
7.476200E-03 |
| Caucasian-vs-AfricanAmerican |
4.892100E-02 |
| Caucasian-vs-Asian |
5.262200E-01 |
| AfricanAmerican-vs-Asian |
1.882410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.449000E-04 |
| Normal-vs-Female |
2.583800E-04 |
| Male-vs-Female |
2.918600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.374300E-02 |
| Normal-vs-Extreme_Weight |
2.740500E-02 |
| Normal-vs-Obese |
8.802900E-04 |
| Normal-vs-Extreme_Obese |
9.753900E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.959000E-01 |
| Normal_Weight-vs-Obese |
1.922240E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.389200E-01 |
| Extreme_Weight-vs-Obese |
1.063770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.025000E-01 |
| Obese-vs-Extreme_Obese |
5.748600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.805500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.89640000000302E-05 |
| Normal-vs-Age(61-80Yrs) |
7.048600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.281610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.596000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.770400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.185170E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.097000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.43189999541372E-08 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.84910000054084E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.92940999999003E-05 |
| Normal-VS-Type2 PRCC |
2.303400E-01 |
| Normal-VS-KIRP CIMP |
2.001400E-03 |
| Normal-VS-Unclassified PRCC |
1.198300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.935700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.990400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.611800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.162300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.544370E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.918200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.862000E-02 |
| Normal-vs-N1 |
6.958900E-03 |
| Normal-vs-N2 |
2.110600E-01 |
| N0-vs-N1 |
1.156810E-01 |
| N0-vs-N2 |
8.019400E-01 |
| N1-vs-N2 |
6.535800E-01 |
|
|
